SecBot SecBot
6-K ·Filed Jun 30, 2026

ATHE

ALTERITY THERAPEUTICS LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001437749-26-022072
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for subsequent filings that may detail the identity and size of the substantial holder change, which could signal insider sentiment or strategic shifts. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ATHE ▼ -33.89% at T+60d
NEUTRAL call -33.89% · α vs SPY -36.71% · entry $5.37 → $3.55
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+1.68%
call +1.68% · α +1.81%
$5.46
settled 4mo ago
T+5d
+9.68%
call +9.68% · α +9.08%
$5.89
settled 4mo ago
T+20d
-13.13%
call -13.13% · α -12.10%
$4.67
settled 3mo ago
T+60d
-33.89%
call -33.89% · α -36.71%
$3.55
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Alterity Therapeutics filed a Form 6-K on June 30, 2026, reporting a change in substantial holding (Exhibit 99.1). The filing is a routine disclosure of a shift in a major shareholder's position, with no financial figures, business updates, or material events provided. This is an administrative filing with no immediate price impact.

Key Facts

  • Filed Form 6-K on June 30, 2026, reporting a change in substantial holding.
  • Exhibit 99.1 discloses the change but contains no financial data or business updates.
  • No revenue, earnings, guidance, or material operational information is included.

Financial Impact

No financial impact disclosed; the filing is a routine ownership disclosure.

Risk Factors

  • Lack of transparency on the holder's identity or transaction size may lead to uncertainty.
  • Potential for future dilution or control changes if the substantial holder is an activist or large investor.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001437749-26-022072
Document: 0001437749-26-022072-index-headers.html0001437749-26-022072
Document: 0001437749-26-022072-index.html0001437749-26-022072
Document: 0001437749-26-022072.txt0001437749-26-022072
42 reports for ATHE
Performance horizon
67% Hit rate @ T+60 4 of 6 directional calls Went positive at some point 10 of 10 best @ T+20▲ +27.97%Jun 9, 2026
Filters
Rows
Reports for ATHE — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
6-K
BEARISH ★ 6/10
$2.09awaiting T+60—$2.08 (+0.48%)
Oct 23, 2026
4d ago
6-K
NEUTRAL ★ 2/10
$2.09awaiting T+60—$2.08 (−0.48%)
Oct 23, 2026
4d ago
6-K
NEUTRAL ★ 2/10
$2.09awaiting T+60—$2.08 (−0.48%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$2.39awaiting T+60—$2.08 (−12.97%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$2.39awaiting T+60—$2.08 (−12.97%)
Oct 19, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$2.43awaiting T+60—$2.08 (−14.40%)
Oct 9, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$3.12awaiting T+60—$2.08 (−33.33%)
Oct 5, 2026
21d ago
Press Release
BULLISH ★ 8/10
$3.22awaiting T+60—$2.08 (−35.40%)
Oct 5, 2026
22d ago
6-K
BULLISH ★ 6/10
$3.22awaiting T+60—$2.08 (−35.40%)
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.67awaiting T+60—$2.08 (−43.32%)
Showing 10 of 42

US Market Status

Market Closed — Opens in 3h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026